Upstream Commerce said it raised an additional $3 million in funding from YL Ventures, Bright Capital and other private investors. The money will go toward product and technology development.
You are browsing the archive for Bright Capital - peHUB.
BASF Venture Capital has put $5 million into Solidia Technologies, a maker of building and construction materials, as part of a $27 million financing round. The round also includes participation from Kleiner Perkins Caufield and Byers, BP Ventures and Bright Capital, the venture arm of RU-COM Corp. PRESS RELEASE BASF Venture Capital GmbH is investing [...]
BASF Venture Capital is investing $5 million in Solidia Technologies as part of a $27 million financing round. The current round of financing also includes Kleiner Perkins Caufield and Byers, BP Ventures and Bright Capital, the venture arm of RU-COM Corporation. The company is headquartered in Piscataway (New Jersey) and has 28 employees. PRESS RELEASE [...]
SuVolta, a developer of PowerShrink(TM) low-power IC technology that cuts chip power consumption by 50 to 90 percent, has secured $17.6 million in venture funding. New investor Bright Capital participated in the round, joining existing SuVolta investors including Kleiner Perkins Caufield & Byers (KPCB), August Capital, New Enterprise Associates (NEA), Northgate Capital, DAG Ventures and [...]
CardioDx, a company developing cardiovascular genomic diagnostics, has raised $60 million in new equity funding. New investors Longitude Capital, J.P. Morgan, Acadia Woods Partners, Artiman Ventures, and Bright Capital, the venture arm of RU-COM, participated in the round, which also included the company’s previous investors. The company has raised money previously from Kleiner, Perkins, Caufield & Byers, Mohr Davidow Ventures, TPG Biotech, Intel Capital, Pappas Ventures, DAG Ventures, Asset Management Group and GE Capital. Funding will be used to expand reimbursement coverage in the United States for the company’s blood-based gene expression test for obstructive coronary artery disease, as well as to continue development of future products. The company, based in Palo Alto, Calif., closed a $45 million round in May 2010.